Wang Lai

President, Global Head of R&DBeOne Medicines Ltd. (ONC) · full profile →Form 4 · filed Jun 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$197K
Net Open-Market Flow
-$197K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 11, 2026Grant(A)119K$01.7M
Jun 11, 2026Sell(S)756$261.00$197K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 11, 2026Grant(A)230K$0230K

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001852291-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly: